Nivatrotamab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nivatrotamab, covering 2023-08-14 to 2023-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Clinical Activity of Nivatrotamab in Relapsed/Recurrent Metastatic Small-cell Lung Cancer [Phase 1, Phase 2]